Plasmodium Falciparum Malaria
Showing 26 - 50 of 70
Malaria, Plasmodium Falciparum Malaria Trial in Silver Spring (Falciparum Malaria Protein 11 with AS02A adjuvant)
Completed
- Malaria
- Plasmodium Falciparum Malaria
- Falciparum Malaria Protein 11 with AS02A adjuvant
-
Silver Spring, MarylandWalter Reed Army Institute of Research
May 15, 2018
Plasmodium Falciparum Malaria Trial in Silver Spring (Falciparum Malaria Protein 11 with AS01B adjuvant.)
Completed
- Plasmodium Falciparum Malaria
- Falciparum Malaria Protein 11 with AS01B adjuvant.
-
Silver Spring, MarylandWalter Reed Army Institute of Research
May 3, 2018
Plasmodium Falciparum Malaria Trial in Bamako (FMP2.1/AS02A, Rabies Vaccine)
Completed
- Plasmodium Falciparum Malaria
- FMP2.1/AS02A
- Rabies Vaccine
-
Bamako, MaliUniversity of Bamako, Malaria Research and Training Center
Oct 11, 2018
Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria Trial in Timika (dihydroartemisinin-piperaquine)
Completed
- Plasmodium Falciparum Malaria
- Plasmodium Vivax Malaria
-
Timika, Papua, IndonesiaTimika Research Facility
Jul 31, 2018
Malaria, Malaria Vaccines, Plasmodium Falciparum Malaria Trial (Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine)
Withdrawn
- Malaria
- +2 more
- Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine
- (no location specified)
Jul 3, 2018
Artemisinin-resistant Malaria in Cambodia
Completed
- Plasmodium Falciparum Malaria
-
Phnom Penh, CambodiaNational Center for Parasitology, Entomology, and Malaria Contro
May 31, 2018
Histidine Rich Protein 2 Highly Sensitive Rapid Diagnostic Test
Unknown status
- Plasmodium Falciparum Malaria
- +2 more
- HS-RDT
- (no location specified)
Mar 6, 2018
Plasmodium Falciparum Malaria Trial in Kombewa (FMP1/AS02A Malaria vaccine, Imovax Rabies vaccine)
Completed
- Plasmodium Falciparum Malaria
- FMP1/AS02A Malaria vaccine
- Imovax Rabies vaccine
-
Kombewa, Nyanza Province, KenyaWalter Reed Project Kombewa Clinic
May 4, 2017
Malaria, Plasmodium Falciparum Malaria Trial in Bamako (FMP2.1/AS02A, Rabies vaccine (RabAvert))
Completed
- Malaria
- Plasmodium Falciparum Malaria
- FMP2.1/AS02A
- Rabies vaccine (RabAvert)
-
Bamako, MaliUniversity of Bamako, Malaria Research and Training Center
Apr 25, 2017
Plasmodium Falciparum Malaria Trial in Bamako (AMA1-C1, AMA1-C1/alhydrogel Malaria Vaccine)
Completed
- Plasmodium Falciparum Malaria
- AMA1-C1
- AMA1-C1/alhydrogel Malaria Vaccine
-
Bamako, MaliMalaria Research and Training Center (MRTC)
Jun 30, 2017
Plasmodium Falciparum Malaria, Vaccines Trial in Lenexa (MSP1(42)-FVO & MSP1(42)-3D7)
Completed
- Plasmodium Falciparum Malaria
- Vaccines
- MSP1(42)-FVO & MSP1(42)-3D7
-
Lenexa, KansasQuintiles Phase 1 Services
Jun 30, 2017
Malaria, Plasmodium Falciparum Malaria Trial in Tübingen (PfSPZ Challenge, 0.9% Sodium Chloride (Placebo))
Completed
- Malaria
- Plasmodium Falciparum Malaria
- PfSPZ Challenge
- 0.9% Sodium Chloride (Placebo)
-
Tübingen, GermanyInstitute of Tropical Medicine, University of Tuebingen, Wilhelm
May 12, 2017
Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria Trial in Iquitos (DSM265 400mg, DSM265 xmg, DSM265 ymg)
Completed
- Plasmodium Falciparum Malaria
- Plasmodium Vivax Malaria
- DSM265 400mg
- +2 more
-
Iquitos, Departamento de Loreto (Amazonía Peruana), PeruClínica de la Asociación Civil Selva Amazónica
Jun 21, 2016
Artemisinin Resistance Malaria in Myanmar
Completed
- Drug Resistance
- Plasmodium Falciparum Malaria
- First line antimalarial in Myanmar (artemether-lumefrantrine, dihydroartemisinin-piperaquine, and artesunate-mefloquine)
-
Yangon, MyanmarDr. Myat Phone Kyaw
Jun 7, 2016
Malaria, Plasmodium Falciparum Malaria Trial in Bagamoyo (PfSPZ Vaccine, Normal Saline (Placebo), PfSPZ Challenge)
Completed
- Malaria
- Plasmodium Falciparum Malaria
- PfSPZ Vaccine
- +2 more
-
Bagamoyo, TanzaniaBagamoyo Research and Training Center, Ifakara Health Institute,
Apr 25, 2016
Plasmodium Falciparum Malaria Trial in United Kingdom (RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01), RTS,S/AS01B
Completed
- Plasmodium Falciparum Malaria
- RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01)
- +3 more
-
Southampton, Hampshire, United Kingdom
- +3 more
Dec 2, 2015
Plasmodium Falciparum Malaria, Malaria Trial in Lambaréné (PfSPZ Challenge)
Completed
- Plasmodium Falciparum Malaria
- Malaria
- PfSPZ Challenge
-
Lambaréné, GabonCentre de Recherches Médicales de Lambaréné
Apr 21, 2015
Plasmodium Falciparum Malaria Trial in Oxford, London, Southampton (ChAd63-MVA CS, ChAd63-MVA ME-TRAP, Controlled Human Malaria
Completed
- Plasmodium Falciparum Malaria
- ChAd63-MVA CS
- +2 more
-
Oxford, Oxfordshire, United Kingdom
- +2 more
Feb 12, 2015
Plasmodium Falciparum Malaria Trial in Southampton, Oxford, London (FMP2.1/AS01B)
Completed
- Plasmodium Falciparum Malaria
- FMP2.1/AS01B
-
Southampton, Hampshire, United Kingdom
- +2 more
Jan 8, 2015
Plasmodium Falciparum Malaria Trial in Southampton, Oxford, London (RTS,S/AS01B, ChAd63 ME-TRAP, MVA ME-TRAP)
Completed
- Plasmodium Falciparum Malaria
- RTS,S/AS01B
- +2 more
-
Southampton, Hampshire, United Kingdom
- +3 more
Sep 30, 2014
Plasmodium Falciparum Malaria Trial in Dar es Salaam (Artemether-lumefantrine)
Completed
- Plasmodium Falciparum Malaria
-
Dar es Salaam, TanzaniaMuhimbili University of Health and Allied Sciences
Mar 17, 2014
Plasmodium Falciparum Malaria Trial in Ouagadougou, Navrongo, Rwinkwavu (Artemether Sublingual Spray, Quinine)
Completed
- Plasmodium Falciparum Malaria
- Artemether Sublingual Spray
- Quinine
-
Ouagadougou, Burkina Faso
- +2 more
Jan 27, 2014
Plasmodium Falciparum Malaria Trial in Nijmegen (Chloroquine prophylaxis, Immunization, Plasmodium falciparum Bloodstage
Completed
- Plasmodium Falciparum Malaria
- Chloroquine prophylaxis
- +4 more
-
Nijmegen, NetherlandsRadboud University Nijmegen Medical Centre
Jan 20, 2014
Plasmodium Falciparum Malaria Trial in Southampton, Oxford, London (ChAd63 CS/ME-TRAP, MVA CS/ME-TRAP, ChAd63 CS/ME-TRAP/AMA1)
Completed
- Plasmodium Falciparum Malaria
- ChAd63 CS/ME-TRAP
- +4 more
-
Southampton, Hampshire, United Kingdom
- +2 more
Nov 8, 2013
Plasmodium Falciparum Malaria Trial in Rochester (AMA1-C1/Alhydrogel®, CPG 7909 Oligodeoxynucleotide (VaxImmune®))
Completed
- Plasmodium Falciparum Malaria
- AMA1-C1/Alhydrogel®
- CPG 7909 Oligodeoxynucleotide (VaxImmune®)
-
Rochester, New YorkUniversity of Rochester
May 30, 2013